Dairy products, calcium, and prostate cancer risk in the physicians' health study

American Journal of Clinical Nutrition

Volumn 74, Issue 4, 2001, Pages 549-554

  Chan, June M ^a   Stampfer, Meir J ^b   Ma, Jing ^b   Gann, Peter H ^b   Gaziano, J Michael ^b   Giovannucci, Edward L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

1,25 dihydroxyvitamin D3; Calcium; Dairy products; Diet; Physicians' Health Study; Prostate cancer; Vitamin D

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; CALCITRIOL; CALCIUM;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALCIUM INTAKE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; EXERCISE; FOLLOW UP; FOOD INTAKE; HUMAN; MALE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SMOKING; UNITED STATES; VITAMIN D DEFICIENCY;

EID: 0034823316     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/74.4.549     Document Type: Article

References (48)

1. Prostate cancer
2. Risk factors for prostate cancer
3. Diet, nutrition, and prostate cancer
4. 2 vitamin D and prostate cancer: A hypothesis
5. Vitamin D and prostate cancer: A prediagnostic study with stored sera
6. Calcium and fructose intake in relation to risk of prostate cancer
7. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer
8. Diet and prostate cancer risk in a cohort of smokers, with a specific focus calcium and phosphorous (Finland)
9. Animal products, calcium, and protein and prostate cancer risk in the Netherlands Cohort Study
10. Dietary factors and risk for prostate cancer among blacks and whites in the United States
11. Diet and cancer of the prostate: A case-control study in Greece
12. Dietary beta-carotene and cancer of the prostate: A case-control study in Kyoto, Japan
13. Diet and prostate cancer: A case-control study
14. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer
15. Final report on the aspirin component of the ongoing Physicians' Health Study
16. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
17. Diagnosis, staging, and surgical treatment of prostatic carcinoma (clinical conference)
18. Nutritional epidemiology
19. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States
20. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-Year follow-up of the prospective Basel study
21. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
22. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer
23. Calcium and phosphate
24. Vitamin D
25. Geographic patterns of prostate cancer mortality
26. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
27. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)
28. Vitamin D and prostate cancer
29. Is vitamin D deficiency a risk factor for prostate cancer?
30. 3 receptors and actions in human prostate cancer cell lines
31. 3 on primary cultures of human prostatic cells
32. 3 in androgen-dependent LNCaP cells
33. Control of LNCAP proliferation and differentiation: Actions and interactions of androgens. 1α.25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacelate
34. 3 in seven human prostatic carcinoma cell lines
35. 3 and vitamin D analogs
36. Vitamin D
37. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
38. 3
39. 1α.25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
40. 3 and prostate cancer cell proliferation in vivo
41. Suppression of colonic carcinogenesis by vitamin D in rats
42. Chemopreventive acitivity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate
43. Serum vitamin D metabolite levels and the subsequent development of prostate cancer
44. Association of prostate cancer with vitamin D receptor gene polymorphism
45. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population
46. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians